ArticleJCI insight2026

Peptide-phosphorodiamidate morpholino oligomer therapy for dysferlinopathy induces pseudoexon skipping and restoration of functional protein.

James E Gooding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.